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ABSTRACT 
LH-RH test, HCG test and testicular biopsy were performed III 7 boys with Prader-Labhart-
Willi syndrome (PLWS) in whom bilateral cryptorchidism was observed. The age of patients ranged 
7-1/6 to 15-1/12 years. Six out of7 patients had no pubertal signs and the basal levels of serum LH, 
FSH and testosterone were low. Furthermore, no significant responses of serum LH and FSH to 
LH-RH stimulation and of testosterone to HCG were observed. Histological examination of the 
testes in these six patients revealed the seminiferous tubules containing reduced numbers of immature 
germ cells in 6 cases and interstitial fibrosis in 3 cases. However, the basal values of LH, FSH and 
testosterone in lout of seven cases with pubertal signs were higher than those in remaining 6 cases 
and significant hormonal responses to LH-RH stimulations were demonstrated. In the seminiferous 
tubule of the last patient, spermatocytes and spermatids were found. These findings suggest that 
different patterns of disturbance of hypothalamo-pituitary-gonadal system are present in male patients 
with PLWS. 
PLWS, originally described in 1956 by 
Prader, Labhart and Willi, is characterized 
by neonatal and early infancy hypotonia, 
mental deficiency, hypogonadism and early 
childhood onset of obesity. In these main 
symptoms, the cause of hypogonadism is 
still obscure. In male patients with PLWS, 
a high incidence of cryptorchidsm has been 
reported (Hall & Smith, 1972). The present 
paper shows the pituitary-gonadal functions 
and histological findings of the testes in 7 
patients with PLWS (1972). 
MA TERIALS AND METHOD 
Seven male patients were diagnosed as 
PLWS by past history and physical findings 
(Table 1, Figure 1). They were 15-1/12, 
14-2/3, 12-11/12, 11-1/2, 11-1/12, 7-1/2 and 
7-1/6 years old, respectively, and the cases 
3 and 4 were brothers. In cases 2 and 5, 
bilateral orchiopexy and testicular biopsy 
had been performed at 6-1/2 and 7-1/6 
years of age, respectively (Okuyama et al., 
1976). The findings of external genitalia 
were stage PI in all but the case 2 who was 
in the stage P2 (Marshall & Tanner, 1970). 
The endocrinological examinations were 
made in the following way. Blood samples 
were taken at 9 ;00 a.m. in quiet and empty 
stomach, and then synthetic luteinizing 
hormone releasing hormone (LH-RH), 100 
pg/m2 body surface area was administered 
intraveneously. Blood samples were taken 
30, 60, 90 and 120 min. after the administ-
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Table 1. Ph ysical and endocrinological findings in seven patien ts wi th Prader-
Labhart-Willi syndrome 
Case Age 
'p* Height Weight Basal Peak Basal Peak Basal 
No. stage !em) Ikg) lH** lH FSH** FSH T**" 
I 15 -I 112 I 148 60 I 2 3 0.4 
2 14-2/3 2 152 49 5 14 4 12 1.5 
3 12 -1 1/12 134 45 2 3 2 2 0 . 3 
4 II-lIZ 130 43 I 3 2 0.4 
5 I I -1/12 126 42 2 2 2 0.3 
6 7 -I I 2 14 32 2 0 . 3 
7 7 -1/6 I II 28 2 03 
* P stage: pube rta l stage I PI-P5), * * lH, FSH: serum lH, FSH I mIU/ml), 










Fig. I. Body statures of seven patients with Prader-Labh art-\Villi syndrome 
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ration and LH and FSH levels in serum 
obtained before and after the administration 
were determined. One week after the 
LH-RH administration, blood samples were 
taken at 9 :00 a.m. in quiet and empty 
stomach and then human chorionic gonado-
tropin (HCG) 3,000 IU 1m2 body surface 
area was administered intramuscularly for 
five consecutive days. Blood samples were 
taken 6 hours after the 5th administration 
and serum testosterone levels were deter-
mined. Within one week after the HCG 
administration, bilateral orchiopexy and 
right testicular biopsy were performed in 
five cases (cases 1, 3, 4, 6 and 7). The 
right testicular biopsy in the case 2 and 5 
was made by scrotal incision. The speci-
mens taken were fixed with Bouin's solution 
and stained with hematoxylin and eosin for 
microscopic examinations. For therapeutic 
purpose, 5,000 IU 1m2 body surface of HCG 
was injected intramuscularly twice a week 
for 15 weeks and 8 weeks in cases 1 and 3 
and cases 4, 5, 6 and 7 respectively. Serum 
testosterone levels were measured immedia-
tely after every fifth injection. 
Serum levels of LH and FSH were 
determined by double antibody radioim-
munoassay as described previously (Aono et 
al.,1972). Human pituitary LH and FSH, 
which were obtained from Calbiochem., 
Jolla, Calif., U.S.A. were labeled 125I. 
Antisera, also obtained from Calbiochem., 
were diluted with 0.01 M phosphate buffer-
ed saline (pH 7.6) containing 1 % normal 
rabbit serum. Two IU of HCG was added 
per tube to enhance the specificity in FSH 
assay. The separation of bound from free 
was achieved by sheep antirabbit r-globulin 
serum. The 2nd International Reference 
of Human Menopausal Gonadotropin was 
performed in duplicate using 0.1-0.4 ml of 
serum per tube. The minimal detectable 
dose was 0.5 mIU Iml in the LH assay and 
1.0 mIU Iml in the FSH assay. The intra-
and interassay coefficient of variation in the 
normal male range obtained from 8 assays 
were respectively, 9.0 and 14.1 % in the LH 
assay and 13.3 and 19.4% in the FSH assay. 
Specificity study of the assay revealed less 
than 1 % cross-reaction by weight for synthe-
tic human adrenocorticotropin (Richter, 
Bhl - 39l , human growth hormone (Wilhermi) 
and human FSH (Calbiochem.), and less 
4% for human thyrotropin (Condliff). FSH 
assay was also specific for human FSH 
having less than 1 % cross-reactivity by 
weight for human adrenocorticotropin, 
growth hormone, thyrotropin, LH (Calbio-
chern.) and HCG (Teizo). 
The serum testosterone level was measur-
ed by radioimmunoassay (Yoshimi et al., 
1972) with slight modifications. The anti-
serum was prepared in rabbit by immuni-
zation with testosterone-3-carboxymethyl-
oxime-bovine serum albumin. The radio-
active steroid used was [1.2-3H] testosterone 
(Daiichi Pure Chemical), 40 Ci/mmol. 
The separation of free from bound was 
achieved by the dextran-coated charcoal 
method. The assay was performed in 
duplicate using 0.1-0.5 ml of serum per tube. 
For the estimation of low basal levels of 
serum testosterone in the prepubertal boys 
a more diluted antiserum and 0.5 ml serum 
were used. The minimal detectable dose 
was 0.06 ng/ml. The intra- and interassay 
coefficient of variation in male serum range 
obtained from 10 assays were 8.2 and 9.9%, 
respectively. The antiserum used cross-
reacts with Sa-reduced androstane-5a-di-
hydrotestosterone (65 %), 5a-androstane-3a, 
l7j3-diol (17%) and 5a-androstane-3j3, 
17j3-diol (7%) but not with estradiol-17j3, 
progesterone, cortisol or corticosterone. 
RESULT 
In six patients without pubertal SIgns 
(PI), serum LH and FSH levels were 
invariably low, and serum testosterone 
levels were less than 1.0 nglml in all cases. 
In addition, no significant response in the 
levels of LH, FSH and testosterone were 
found by the LH-RH and HCG tests in 
these six patients (Table 1). In case 2 
with pubertal changes, on the other hand, 
serum LH, FSH and testosterone levels 
were higher than those in six patients with-
out pubertal signs, and significant responses 
to both LH-RH and HCG stimulations 
were found (Table 1). The peak levels of 
serum testosterone in cases 1, 3, 4, 5, 6 and 
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Fig. 7 
Legend fo r Fig. 2-8 
Case I. M agni fication x 200. The seminiferous 
tubules contain small numbers o f immature Sertoli 
ce li s and spermatogonias. Intersti a l fibrosis is mode-
rate and clusters of mature Leydig ce lls are not 
found (prepuber ta l testis) . Case 2. M agnification 
x 100. The seminiferous tubules contain normal 
numbers of sperm~tocy tes a nd spermatids. C luste rs 
of mature Leydig ce ll s are found in the right upper 
corner of the picture (puberta l testis). Case 3, 4 
and 5. M agnifications x 200, x 200 and x 400. The 
seminiferous tubules conta in slightly small numbers 
of immature Sertoli ce lls and sperma togonias. 
C lusters of mature Leydig ce lls are not fouud 
(prepubertal testes) . Case 6. M agnification x 200. 
The sem iniferous tubu les are slight ly thickened and 
contain small numbers of immature Sertoli ce lls 
and spermatogonias. Interstiti a l fibrosis is moderate 
and clusters of mature Leydig ce ll s are not found 
(prepubertal testis) . Case 7. M agnification x 200. 
The seminiferous tubules contain sma ll numbers 
of immature Sertoli ce ll s and spermatogonias. 
Intestitia l fibrosis is moderate a nd clusters o f mature 
Leydig ce lls (prepuberta l tes ti s) . 
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7 (without pubertal signs) during the 
therapeutic HCG injections were 0.6, 0.4, 
0.5, 0.3, 0.5 and 0.5 ng/ml, respectively, 
showing no significant responses by repeated 
HCG stimulations. 
Histological findings of testicular biopsy 
in case 1 showed atrophic prepubertal testis 
with reduced numbers of immature Sertoli 
cells and spermatogonias and moderate 
interstitial fibrosis (Figure 2). In case 2, 
the seminiferous tubules were filled with 
normal numbers of spermatocytes and 
spermatids and clusters of Leydig cells were 
found in the interstitial tissue (Figure 3). 
In cases 3, 4 and 5, the seminiferous tubules 
were composed solely of immature Sertoli 
cells and spermatogonias, showing a definite 
picture of prepubertal testis (Figure 4~6). 
Cases 6 and 7 showed the finding of 
prepubertal testis with reduced numbers of 
immature Sertoli cells and spermatogonias, 
and interstitial fibrosis (cases 6 and 7) and 
tubular thickening (case 6) were also found 
(Figure 7~8). 
DISCUSSION 
Hypogonadism is one of the commonly 
described clinical feature of PL WS (Zell-
weger & Schneider, 1968). In male 
patients, small phallus and testes, hypo-
plastic scrotum, and high frequency of 
abdominal or inguinal testicular retention 
are found, and the appearance of secondary 
sexual characteristics is generally delayed 
(Zellweger & Schneider, 1968; Hamilton et 
al.,1972; Hall & Smith, 1972; Wannarachue 
et al., 1975). Recent findings in PLWS 
have shown that patients without pubertal 
signs show low levels of serum and urinary 
gonadotropin (Laurence, 1967; Hamilton 
et al., 1972). However, patients with high 
gonadtropin levels have also J;een reported 
(Seyler et al., 1979). In patients with 
pubertal sign, gonadotropin levels have 
been reported to be invariably within the 
normal range (Hamilton et al., 1972 ; 
Wannarachue et al., 1975). The present 
findings shown in Table 1 confirm these 
observations. There are not many reports 
dealing with response of gonadotropin to 
LH-RH in PWLS, but significant responses 
to LH-RH in some prepubertal patients 
have been reported (Morgner et al., 1974; 
Seyler et al., 1979). Although the above 
observation is inconsistent with our finding 
shown in Table 1, the patients examined by 
others were invariably older than those 
reported in this paper. In connection with 
the response of testosterone level to HCG 
stimulation in patients with PL WS, respon-
sive (Tolis et al., 1974; Wannarachue et al., 
1975) or nonresponsive (Seyler et al., 1979) 
findings have been reported. Our findings 
clearly demonstrated that patients without 
pubertal sign showed no responses to 
LH-RH as well as HCG stimulations, while 
those with pubertal signs responded signifi-
cantly to both LH-RH and HCG stimula-
tions. 
In regard to the histological findings of 
testes in PL WS normal findings in some 
patients (Zellweger & Schneider, 1968), 
and abnormal findings such as decreased 
numbers of germ cells, small atrophic 
tubules, tubuler thickning in the other 
patients (Hamilton et al., 1972; Wanna-
rachue et al., 1975) have been reported. 
Our patient with pubertal signs showed 
normal testicular histology but those wi-
thout pubertal signs showed the abnormal 
findings. 
There are two possibilities for the 
pathogenesis of hypogonadism in PL WS : 
(1) Hypothalamic disorder from the fetal 
period causes irreversible change in 
pituitary gonadal axis. (2) Maturation in 
hypothalamo-pituitary system is only delay-
ed. If the former is true, gonadotropin 
levels cannot be increased to LH -RH 
stimulation and long-term administration of 
HCG cannot be effective. If the latter is 
true, onset of puberty may possibly be 
induced by long-term administration of 
LH-RH or HCG. Since our patients 
without pubertal signs showed no response 
to both LH-RH and HCG administrations, 
it seems that irreversible change in pituitary 
and Leydig cell is induced by hypothalamic 
disorders in these patients. But from report 
of other authors investigating other type of 
hypo gonadotropic hypogonadism, a longer 
HCG therapy than ours might be needed 
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for conclusion that irreversible changes in 
Leydig cells exist (Betend et al., 1977). 
The findings in many patients with PL WS 
reported by us and other investigators have 
shown that there are positive and negative 
responses to clomid, LH-RH and HCG 
administrations (Hamilton et al., 1972; 
Hall & Smith, 1972; Jeffcoate, 1980; Tolis 
et al., 1972; Wannarachue et aI., 1975; 
Seyler et al., 1979). The pathogenesis of 
hypogonadism in PLWS is left unclarified. 
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両 側 停 留 睾 丸 を 合 併 した71/6～151/12のPrader-
Labhart-Willi症 候 群(PLWS)7例 に 対 してLH-RH,
HCG両 負 荷 試 験 お よ び 睾 丸 生 検 術 を 施 行 し た.6
例 に は 第二 次 性 徴 の 発 来 は 無 く,血 中LH,FSH,
testosteroneは 低 値 で,さ らにLH-RH,HCG8?対
して 有 意 の 反 応 は み とめ られ なか っ た.以 上6例 の 睾
丸組 織 像 に お い て,精 祖 細 胞 の 減 少 を 全例 に,ま た 間
質の線維化を3例 にみとめた.一 方,他 の1例 には第
二次性徴の発来をみてお り,血 申LH,FSH,testo-
steroneは 他の ものより高値を呈 し,LH-RH,HQG}こ
対 して も有意の反応をみ,加 えて精細管中には精母細
胞,精 子細胞をみとめた.以 上の所見か らPLWSの
中には,異 つた視床下部下垂体性腺系障害を有する症
例が存在す ることが想定された.
